Published ahead of print on March 6, 2003, doi:10.1165/rcmb.2002-0152OC
Am. J. Respir. Cell Mol. Biol., Volume 29, Number 2, August 2003, 206-212
A more recent version of this article appeared on August 1, 2003
Submitted on August 13, 2002
Revised on March 4, 2003
Lactoperoxidase and Human Airway Host Defense
Corinne Wijkstrom-Frei1, Souheil El-Chemaly1, Radia Ali-Rachedi2, Cynthia Gerson2, Miguel A Cobas3, Rosanna Forteza1, Matthias Salathe1, and Gregory E Conner2*
1 Division of Pulmonary and Critical Care Medicine,Department of Medicine, University of Miami School of Medicine, Miami, FL, USA,
2 Cell Biology and Anatomy, University of Miami School of Medicine, Miami, FL, USA,
3 Anesthesiology, University of Miami School of Medicine, Miami, FL, USA
* To whom correspondence should be addressed. E-mail: gconner{at}miami.edu.
The lactoperoxidase (LPO) antibiotic system is a well-characterized component of mammary and salivary gland secretions. Since LPO has been shown to function in ovine airways, human airway tissue and secretions were examined for the presence of LPO and its substrate, the anion thiocyanate (SCN-). In addition, human airway secretions were tested for LPO-mediated antibacterial activity and LPO's activity was assessed against some human airway pathogens. The data showed that normal human airway secretions contained LPO enzyme activity (0.65 ± 0.09 µg/mg secreted protein; n = 17) and Western blots of secretions demonstrated bands of the expected sizes for LPO. LPO mRNA was detected in trachea by sequencing PCR amplified cDNA. SCN-, LPO's substrate, was present in undiluted airway secretions at concentrations sufficient for LPO catalysis (0.46 ± 0.19 mM; n = 8) and diluted secretions contained antibacterial activity with LPO-like properties. Immunocytochemistry localized LPO to submucosal glands in human bronchi. Finally, as expected based on the known antibacterial spectrum of the LPO system, airway secretions showed LPO-dependent activity against Pseudomonas aeruginosa. In addition, the airway LPO system was shown to be effective against Burkholderia cepacia and Haemophilus influenzae. Thus, a functional LPO system exists in human airways and may contribute to airway host defense against infection.
This article has been cited by other articles:

|
 |

|
 |
 
B. Rada, K. Lekstrom, S. Damian, C. Dupuy, and T. L. Leto
The Pseudomonas Toxin Pyocyanin Inhibits the Dual Oxidase-Based Antimicrobial System as It Imposes Oxidative Stress on Airway Epithelial Cells
J. Immunol.,
October 1, 2008;
181(7):
4883 - 4893.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S. Rogers, W. M. Abraham, K. A. Brogden, J. F. Engelhardt, J. T. Fisher, P. B. McCray Jr., G. McLennan, D. K. Meyerholz, E. Namati, L. S. Ostedgaard, et al.
The porcine lung as a potential model for cystic fibrosis
Am J Physiol Lung Cell Mol Physiol,
August 1, 2008;
295(2):
L240 - L263.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Fischer, L. K. Gonzales, V. Kolla, C. Schwarzer, F. Miot, B. Illek, and P. L. Ballard
Developmental regulation of DUOX1 expression and function in human fetal lung epithelial cells
Am J Physiol Lung Cell Mol Physiol,
June 1, 2007;
292(6):
L1506 - L1514.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Pedemonte, E. Caci, E. Sondo, A. Caputo, K. Rhoden, U. Pfeffer, M. Di Candia, R. Bandettini, R. Ravazzolo, O. Zegarra-Moran, et al.
Thiocyanate Transport in Resting and IL-4-Stimulated Human Bronchial Epithelial Cells: Role of Pendrin and Anion Channels
J. Immunol.,
April 15, 2007;
178(8):
5144 - 5153.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Moskwa, D. Lorentzen, K. J. D. A. Excoffon, J. Zabner, P. B. McCray Jr., W. M. Nauseef, C. Dupuy, and B. Banfi
A Novel Host Defense System of Airways Is Defective in Cystic Fibrosis
Am. J. Respir. Crit. Care Med.,
January 15, 2007;
175(2):
174 - 183.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Wright, C. A. Merlo, J. B. Reynolds, P. L. Zeitlin, J. G. N. Garcia, W. B. Guggino, and M. P. Boyle
Respiratory Epithelial Gene Expression in Patients with Mild and Severe Cystic Fibrosis Lung Disease
Am. J. Respir. Cell Mol. Biol.,
September 1, 2006;
35(3):
327 - 336.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Casalino-Matsuda, M. E. Monzon, and R. M. Forteza
Epidermal Growth Factor Receptor Activation by Epidermal Growth Factor Mediates Oxidant-Induced Goblet Cell Metaplasia in Human Airway Epithelium
Am. J. Respir. Cell Mol. Biol.,
May 1, 2006;
34(5):
581 - 591.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Sermon, E. M.-R. P. Wevers, L. Jansen, P. De Spiegeleer, K. Vanoirbeek, A. Aertsen, and C. W. Michiels
CorA Affects Tolerance of Escherichia coli and Salmonella enterica Serovar Typhimurium to the Lactoperoxidase Enzyme System but Not to Other Forms of Oxidative Stress
Appl. Envir. Microbiol.,
November 1, 2005;
71(11):
6515 - 6523.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Forteza, M. Salathe, F. Miot, R. Forteza, and G. E. Conner
Regulated Hydrogen Peroxide Production by Duox in Human Airway Epithelial Cells
Am. J. Respir. Cell Mol. Biol.,
May 1, 2005;
32(5):
462 - 469.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Kettle, T. Chan, I. Osberg, R. Senthilmohan, A. L. P. Chapman, T. J. Mocatta, and J. S. Wagener
Myeloperoxidase and Protein Oxidation in the Airways of Young Children with Cystic Fibrosis
Am. J. Respir. Crit. Care Med.,
December 15, 2004;
170(12):
1317 - 1323.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A Fragoso, V. Fernandez, R. Forteza, S. H Randell, M. Salathe, and G. E Conner
Transcellular thiocyanate transport by human airway epithelia
J. Physiol.,
November 15, 2004;
561(1):
183 - 194.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Sajjan, S. Keshavjee, and J. Forstner
Responses of Well-Differentiated Airway Epithelial Cell Cultures from Healthy Donors and Patients with Cystic Fibrosis to Burkholderia cenocepacia Infection
Infect. Immun.,
July 1, 2004;
72(7):
4188 - 4199.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 American Thoracic Society.
|
|
|